Air Pollution: Practical guidance on how to minimise the impact of air pollution on health

Air pollution poses a serious threat to the environment and exposure can cause a variety of health implications, including effects on lung function and increased risk of respiratory infections. There is a proactive role for community pharmacists to provide advice and support to mitigate the impact of air pollution on patients’ health and quality of life.

This webinar, organised by the International Pharmaceutical Federation (FIP) and GSK’s scientific initiative, The Clean Breathing Institute (TCBI), provides examples of the services and tools which can be used by community pharmacy teams to help enable patients to breathe better and help minimise the impact of air pollution on health.

The webinar content is designed to support pharmacists to:

• Describe the role that they can play in mitigating air pollution in the community
• Identify the different tools available to them to enable the reduction of the impact of air pollution in the community
• Understand the various arrays of services that community pharmacists can employ in supporting better breathing and helping minimise the impact of air pollution on health

Moderator:

Lars-Åke Söderlund, President, FIP Community Pharmacy Section

Speakers & presentation titles:

Daniela Munene, CEO, Pharmaceutical Society of Kenya – ‘Addressing outdoor and indoor air pollution in Kenya: Pharmacy’s role in raising awareness and empowering the community’.

Job FM van Boven, Chair of the Dutch respiratory pharmacists’ group at the Royal Dutch – ‘Community pharmacists’ role in mitigating the impact of air pollution on health – Exploring new professional services’

Emilio Santoro, The Clean Breathing Institute & Medical Affairs Principal Scientist, Respiratory and Skin Health, Global Category, GSK R&D (Switzerland) – ‘Promoting nasal hygiene as an effective way of preventing the effects of air pollution on health’

Event date: 12th August 2021

Language: English

Duration: 1 hour